![Jim Scopa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jim Scopa
Directeur/Membre du Conseil chez
ALIGOS THERAPEUTICS, INC.
Fortune : 41 741 $ au 31/05/2026
Profil
James Paul Scopa is currently Director at Astute Medical, Inc., Independent Director at Aligos Therapeutics, Inc. since 2021, Director at DICE Molecules SV, Inc. since 2020, Director at Neuron23, Inc., and Venture Partner at Oneventures Management.
Former roles include Managing Director at Cash Reserve Fund, Inc., Director at TriVascular, Inc., Independent Director at Conatus Pharmaceuticals, Inc. from 2011 to 2018, Director at Peplin, Inc. from 2006 to 2009, Director at Kalidex Pharmaceuticals, Inc., Managing Director at MPM BioImpact LLC from 2005 to 2017, Director at Nevro Corp., Independent Director at Trivascular Technologies, Inc. from 2008 to 2016, Director at Trivascular2, Inc., Director at Solasia Pharma KK, Director at iPierian, Inc., Director at True North Therapeutics, Inc., Director at Semma Therapeutics, Inc., Independent Director at DICE Therapeutics, Inc. from 2020 to 2023, Director at Blade Therapeutics, Inc. from 2015 to 2023, Independent Director at Adverum Biotechnologies, Inc. from 2019 to 2025, Principal at Thomas Weisel Partners LLC from 2002 to 2004, Principal at Alex.
Brown & Sons, Inc., and Principal at Deutsche Bank Corp.
from 1999 to 2001.
Education includes an MBA from Harvard Business School conferred in 1986, graduate degree from Harvard Law School conferred in 1986, and undergraduate degree from Harvard College conferred in 1980.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/06/2026 | 7 323 ( 0,14% ) | 41 741 $ | 31/05/2026 |
Postes actifs de Jim Scopa
| Sociétés | Poste | Début |
|---|---|---|
| ALIGOS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 27/04/2021 |
DICE Molecules SV, Inc.
 DICE Molecules SV, Inc. Investment ManagersFinance Functions as an alternative investment manager | Directeur/Membre du Conseil | 01/11/2020 |
Neuron23, Inc.
 Neuron23, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that focuses on developing precision medicines for genetically defined neurological and immunological diseases | Directeur/Membre du Conseil | - |
Astute Medical, Inc.
 Astute Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Discovers and develops biomarkers for acute conditions | Directeur/Membre du Conseil | - |
Anciens postes connus de Jim Scopa
| Sociétés | Poste | Fin |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Directeur/Membre du Conseil | 09/12/2025 |
Blade Therapeutics, Inc.
 Blade Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on developing treatments for fibrotic and neurodegenerative diseases | Directeur/Membre du Conseil | 01/09/2023 |
| DICE THER | Directeur/Membre du Conseil | 09/08/2023 |
| HISTOGEN INC. | Directeur/Membre du Conseil | 12/09/2018 |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Private Equity Investor | 01/06/2017 |
Formation de Jim Scopa
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
84
Relations au 1er degré
26
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 26 |
|---|---|
Cash Reserve Fund, Inc.
 Cash Reserve Fund, Inc. Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Miscellaneous |
TriVascular, Inc.
 TriVascular, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical devices | Health Technology |
Conatus Pharmaceuticals, Inc.
 Conatus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company, which engages in the development of human therapeutics to treat liver diseases | Health Technology |
Peplin, Inc.
 Peplin, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and pharmaceutical products | Health Technology |
Astute Medical, Inc.
Astute Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Discovers and develops biomarkers for acute conditions | Electronic Technology |
Kalidex Pharmaceuticals, Inc.
 Kalidex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops antibiotics for the treatment of serious infections | Health Technology |
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Thomas Weisel Partners LLC
 Thomas Weisel Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Alex. Brown & Sons, Inc.
 Alex. Brown & Sons, Inc. Investment Banks/BrokersFinance Provides investment and investment banking services to individuals and entities | Finance |
Nevro Corp.
 Nevro Corp. Medical SpecialtiesHealth Technology Operates as a medical device company | Health Technology |
Deutsche Bank Corp.
 Deutsche Bank Corp. Regional BanksFinance Part of Deutsche Bank AG, Deutsche Bank Corp. is a company based in New York, NY. | Finance |
Trivascular Technologies, Inc.
 Trivascular Technologies, Inc. MiscellaneousMiscellaneous Operates as a holding company | Miscellaneous |
Trivascular2, Inc.
 Trivascular2, Inc. Medical SpecialtiesHealth Technology Develops medical devices | Health Technology |
Solasia Pharma KK
 Solasia Pharma KK Pharmaceuticals: MajorHealth Technology Engages in the development, sale, import and export of pharmaceutical products and medical devices | Health Technology |
iPierian, Inc.
 iPierian, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Law School
 Harvard Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Health Technology |
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative therapies for patients who currently depend on insulin injections | Health Technology |
DICE Therapeutics, Inc.
 DICE Therapeutics, Inc. BiotechnologyHealth Technology Develops oral immunology and other therapeutic products | Health Technology |
Blade Therapeutics, Inc.
Blade Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on developing treatments for fibrotic and neurodegenerative diseases | Health Technology |
Aligos Therapeutics, Inc.
 Aligos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted, curative therapies for hepatologic diseases and viral infections | Health Technology |
DICE Molecules SV, Inc.
DICE Molecules SV, Inc. Investment ManagersFinance Functions as an alternative investment manager | Finance |
Neuron23, Inc.
Neuron23, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that focuses on developing precision medicines for genetically defined neurological and immunological diseases | Commercial Services |
